Morphine-enhanced apoptosis in selective brain regions of neonatal rats

International Journal of Developmental Neuroscience

Volumn 31, Issue 4, 2013, Pages 258-266

  Bajic, Dusica ^a,b   Commons, Kathryn G ^a,b   Soriano, Sulpicio G ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amygdala; Caspase 3; Cortex; Development; Glia; Neurotoxicity

Indexed keywords

CASPASE 3; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN REGION; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; CRANIAL NERVE; EMOTIONALITY; ENZYME MODIFICATION; FEMALE; HIPPOCAMPUS; HOT PLATE TEST; HYPOTHALAMUS; LONG TERM EXPOSURE; MALE; MEMORY; MICROGLIA; NEUROANATOMY; NEWBORN; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PERINATAL PERIOD; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; MORPHINE; MORPHINE DEPENDENCE; RATS; TISSUE DISTRIBUTION;

RATTUS;

EID: 84875673947     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.02.009     Document Type: Article

References (102)

1. Adolphs R., Tranel D., Damasio H., Damasio A.R. Fear and the human amygdala. Journal of Neuroscience 1995, 15:5879-5891.
2. Anand K.J. Consensus statement for the prevention and management of pain in the newborn. Archives of Pediatrics and Adolescent Medicine 2001, 155:173-180.
3. Anand K.J., Garg S., Rovnaghi C.R., Narsinghani U., Bhutta A.T., Hall R.W. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatric Research 2007, 62:283-290.
4. Anand K.J., Hall R.W., Desai N., Shephard B., Bergqvist L.L., Young T.E., Boyle E.M., Carbajal R., Bhutani V.K., Moore M.B., Kronsberg S.S., Barton B.A. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004, 363:1673-1682.
5. Anand K.J., Willson D.F., Berger J., Harrison R., Meert K.L., Zimmerman J., Carcillo J., Newth C.J., Prodhan P., Dean J.M., Nicholson C. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 2010, 125:1208-1225.
6. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neuroscience and Biobehavioral Reviews 2003, 27:3-18.
7. Andersen S.L., Navalta C.P. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs. International Journal of Developmental Neuroscience 2004, 22:423-440.
8. Anderson E.M., Neubert J.K., Caudle R.M. Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala. Neuroscience 2012, 223:45-55.
9. Ashwell K. Microglia and cell death in the developing mouse cerebellum. Brain Research. Developmental Brain Research 1990, 55:219-230.
10. Ashwell K. The distribution of microglia and cell death in the fetal rat forebrain. Brain Research. Developmental Brain Research 1991, 58:1-12.
11. Babey A.M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology 1994, 33:1463-1470.
12. Bajic D., Berde C.B., Commons K.G. Periaqueductal gray neuroplasticity following chronic morphine varies with age: role of oxidative stress. Neuroscience 2012, 226:165-177.
13. Barr G.A., Wang S. Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup. European Journal of Pharmacology 1992, 215:35-42.
14. Beitz A.J. Periaqueductal gray. The Rat Nervous System 1995, 173-182. Academic Press, New York. G. Paxinos (Ed.).
15. Berde C.B., Sethna N.F. Analgesics for the treatment of pain in children. New England Journal of Medicine 2002, 347:1094-1103.
16. Besunder J.B., Blumer J.L. Neonatal drug withdrawal syndromes. Maternal-Fetal Toxicology 1990, 161-177. Marcel Dekker, Inc, New York. G. Koren (Ed.).
17. Blaschke A.J., Staley K., Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996, 122:1165-1174.
18. Boasen J.F., McPherson R.J., Hays S.L., Juul S.E., Gleason C.A. Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology 2009, 95:230-239.
19. Booze R.M., Mactutus C.F. Experimental design considerations: a determinant of acute neonatal toxicity. Teratology 1985, 31:187-191.
20. Chambliss C.R., Anand K.J. Pain management in the pediatric intensive care unit. Current Opinion in Pediatrics 1997, 9:246-253.
21. Che Y., Sun H., Tan H., Peng Y., Zeng T., Ma Y. The effect of prenatal morphine exposure on memory consolidation in the chick. Neuroscience Letters 2005, 380:300-304.
22. Clancy B., Darlington R.B., Finlay B.L. Translating developmental time across mammalian species. Neuroscience 2001, 105:7-17.
23. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
24. Craft R.M., Stratmann J.A., Bartok R.E., Walpole T.I., King S.J. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 1999, 143:1-7.
25. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biological Psychiatry 2002, 51:68-80.
26. Davis M. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends in Pharmacological Sciences 1992, 13:35-41.
27. Davis M. The role of the amygdala in emotional learning. International Review of Neurobiology 1994, 36:225-266.
28. De Felipe J., Marco P., Fairen A., Jones E.G. Inhibitory synaptogenesis in mouse somatosensory cortex. Cerebral Cortex 1997, 7:619-634.
29. de Graaf J., van Lingen R.A., Simons S.H., Anand K.J., Duivenvoorden H.J., Weisglas-Kuperus N., Roofthooft D.W., Groot Jebbink L.J., Veenstra R.R., Tibboel D., van Dijk M. Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: five-year follow-up of a randomized controlled trial. Pain 2011, 152:1391-1397.
30. Emeterio E.P., Tramullas M., Hurle M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. Journal of Neuroscience Research 2006, 83:1352-1361.
31. Ferguson S.A., Ward W.L., Paule M.G., Hall R.W., Anand K.J. A pilot study of preemptive morphine analgesia in preterm neonates: Effects on head circumference, social behavior, and response latencies in early childhood. Neurotoxicology and Teratology 2012, 34:47-55.
32. Fitzgerald M., Walker S.M. Infant pain management: a developmental neurobiological approach. Nature Clinical Practice Neurology 2009, 5:35-50.
33. Fonsmark L., Rasmussen Y.H., Carl P. Occurrence of withdrawal in critically ill sedated children. Critical Care Medicine 1999, 27:196-199.
34. Goswami R., Dawson S.A., Dawson G. Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons. Journal of Neurochemistry 1998, 70:1376-1382.
35. Hassanzadeh K., Habibi-Asl B., Farajnia S., Roshangar L. Minocycline prevents morphine-induced apoptosis in rat cerebral cortex and lumbar spinal cord: a possible mechanism for attenuating morphine tolerance. Neurotoxicity Research 2011, 19:649-659.
36. He X., Bao Y., Li Y., Sui N. The effects of morphine at different embryonic ages on memory consolidation and rewarding properties of morphine in day-old chicks. Neuroscience Letters 2010, 482:12-16.
37. Hu S., Sheng W.S., Lokensgard J.R., Peterson P.K. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002, 42:829-836.
38. Hunt R.W., Tzioumi D., Collins E., Jeffery H.E. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Human Development 2008, 84:29-35.
39. Hutchinson M.R., Bland S.T., Johnson K.W., Rice K.C., Maier S.F., Watkins L.R. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. The Scientific World Journal 2007, 7:98-111.
40. Hutchinson M.R., Northcutt A.L., Hiranita T., Wang X., Lewis S.S., Thomas J., van Steeg K., Kopajtic T.A., Loram L.C., Sfregola C., Galer E., Miles N.E., Bland S.T., Amat J., Rozeske R.R., Maslanik T., Chapman T.R., Strand K.A., Fleshner M., Bachtell R.K., Somogyi A.A., Yin H., Katz J.L., Rice K.C., Maier S.F., Watkins L.R. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. Journal of Neuroscience 2012, 32:11187-11200.
41. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. Journal of Comparative Neurology 1997, 387:167-178.
42. Johannesson T., Becker B.A. Morphine analgesia in rats at various ages. Acta Pharmacologica et Toxicologica (Copenh) 1973, 33:429-441.
43. Jones K.L., Barr G.A. Ontogeny of morphine withdrawal in the rat. Behavioral Neuroscience 1995, 109:1189-1198.
44. Katz R., Kelly H.W., Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Critical Care Medicine 1994, 22:763-767.
45. Konijnenberg C., Melinder A. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development. Child Neuropsychology 2011, 17:495-519.
46. Koob G.F. Brain stress systems in the amygdala and addiction. Brain Research 2009, 1293:61-75.
47. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996, 384:368-372.
48. LaBar K.S., LeDoux J.E., Spencer D.D., Phelps E.A. Impaired fear conditioning following unilateral temporal lobectomy in humans. Journal of Neuroscience 1995, 15:6846-6855.
49. Leone M., Proietti Cecchini A., Mea E., Tullo V., Curone M., Bussone G. Neuroimaging and pain: a window on the autonomic nervous system. Neurological Sciences 2006, 27(Suppl. 2):S134-S137.
50. Leuner B., Gould E. Structural plasticity and hippocampal function. Annual Review of Psychology 2010, 61:111-140. C111-113.
51. Lim G., Wang S., Lim J.A., Mao J. Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis. Neuroscience Letters 2005, 389:104-108.
52. Mao J., Mayer D.J. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Annals of the New York Academy of Sciences 2001, 933:175-184.
53. Mao J., Sung B., Ji R.R., Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. Journal of Neuroscience 2002, 22:7650-7661.
54. Maren S., Aharonov G., Fanselow M.S. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. Behavioral Neuroscience 1996, 110:718-726.
55. McCann M.E., Soriano S.G. Is anesthesia bad for the newborn brain?. Anesthesiology Clinics 2009, 27:269-284.
56. McGlone L., Mactier H., Weaver L.T. Drug misuse in pregnancy: losing sight of the baby?. Archives of Disease in Childhood 2009, 94:708-712.
57. McPherson R.J., Gleason C., Mascher-Denen M., Chan M., Kellert B., Juul S.E. A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology 2007, 92:33-41.
58. Micheva K.D., Beaulieu C. Quantitative aspects of synaptogenesis in the rat barrel field cortex with special reference to GABA circuitry. Journal of Comparative Neurology 1996, 373:340-354.
59. Micheva K.D., Beaulieu C. Development and plasticity of the inhibitory neocortical circuitry with an emphasis on the rodent barrel field cortex: a review. Canadian Journal of Physiology and Pharmacology 1997, 75:470-478.
60. Milton A.L., Lee J.L., Butler V.J., Gardner R., Everitt B.J. Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drug-seeking behaviors. Journal of Neuroscience 2008, 28:8230-8237.
61. Nasiraei-Moghadam S., Kazeminezhad B., Dargahi L., Ahmadiani A. Maternal oral consumption of morphine increases Bax/Bcl-2 ratio and caspase 3 activity during early neural system development in rat embryos. Journal of Molecular Neuroscience 2010, 41:156-164.
62. Nasiraei-Moghadam S., Sherafat M.A., Safari M.S., Moradi F., Ahmadiani A., Dargahi L. Reversal of prenatal morphine exposure-induced memory deficit in male but not female rats. Journal of Molecular Neuroscience 2012, 10.1007/s12031-012-9860-z.
63. Neugebauer V. Subcortical processing of nociceptive information: basal ganglia and amygdala. Handbook of Clinical Neurology 2006, 141-158. Elsevier, Amsterdam. F. Cervero, T.S. Jensen (Eds.).
64. Neugebauer V., Galhardo V., Maione S., Mackey S.C. Forebrain pain mechanisms. Brain Research Reviews 2009, 60:226-242.
65. Neugebauer V., Li W., Bird G.C., Han J.S. The amygdala and persistent pain. Neuroscientist 2004, 10:221-234.
66. Niles J.C., Wishnok J.S., Tannenbaum S.R. Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide 2006, 14:109-121.
67. Oppenheim R.W. Cell death during development of the nervous system. Annual Review of Neuroscience 1991, 14:453-501.
68. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiological Reviews 2010, 90:419-463.
69. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, Orlando, FL. 4th ed.
70. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
71. Perry V.H., Hume D.A., Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 1985, 15:313-326.
72. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 2005, 177:245-255.
73. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
74. Prus A.J., James J.R., Rosecrans J.A. Conditioned place preference. Methods of Behavior Analysis in Neuroscience 2009, CRC Press, Boca Raton. J.J. Buccafusco (Ed.).
75. Rabinowicz T., de Courten-Myers G.M., Petetot J.M., Xi G., de los Reyes E. Human cortex development: estimates of neuronal numbers indicate major loss late during gestation. Journal of Neuropathology and Experimental Neurology 1996, 55:320-328.
76. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993, 262:695-700.
77. Rakic S., Zecevic N. Programmed cell death in the developing human telencephalon. European Journal of Neuroscience 2000, 12:2721-2734.
78. Ramachandra R., Subramanian T. Atlas of the Neonatal Rat Brain 2011, CRC Press, Boca Raton.
79. Sadraie S.H., Kaka G.R., Sahraei H., Dashtnavard H., Bahadoran H., Mofid M., Nasab H.M., Jafari F. Effects of maternal oral administration of morphine sulfate on developing rat fetal cerebrum: a morphometrical evaluation. Brain Research 2008, 1245:36-40.
80. Salvemini D. Peroxynitrite and opiate antinociceptive tolerance: a painful reality. Archives of Biochemistry and Biophysics 2009, 484:238-244.
81. Schwarz J.M., Bilbo S.D. The functional role of microglia and immune molecules in neurodevelopment. The Immune System and the Developing Brain 2012, Morgan & Claypool Life Sciences, San Francisco. J.M. Schwarz, S.D. Bilbo (Eds.).
82. Seatriz J.V., Hammer R.P. Effects of opiates on neuronal development in the rat cerebral cortex. Brain Research Bulletin 1993, 30:523-527.
83. Seymour B., Dolan R. Emotion, decision making, and the amygdala. Neuron 2008, 58:662-671.
84. Simons L., Moulton E., Linnman C., Carpino E., Becerra L., Borsook D. The human amygdala and pain: evidence from neuroimaging. Human Brain Mapping 2012, 10.1002/hbm.22199.
85. Singhal P.C., Bhaskaran M., Patel J., Patel K., Kasinath B.S., Duraisamy S., Franki N., Reddy K., Kapasi A.A. Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. Journal of Immunology 2002, 168:4025-4033.
86. Singhal P.C., Kapasi A.A., Franki N., Reddy K. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology 2000, 100:57-62.
87. Singhal P.C., Kapasi A.A., Reddy K., Franki N., Gibbons N., Ding G. Morphine promotes apoptosis in Jurkat cells. Journal of Leukocyte Biology 1999, 66:650-658.
88. Singhal P.C., Sharma P., Kapasi A.A., Reddy K., Franki N., Gibbons N. Morphine enhances macrophage apoptosis. Journal of Immunology 1998, 160:1886-1893.
89. Slamberova R., Riley M.A., Vathy I. Cross-generational effect of prenatal morphine exposure on neurobehavioral development of rat pups. Physiological Research 2005, 54:655-660.
90. Spratto G.R., Dorio R.E. Effect of age on acute morphine response in the rat. Research Communications in Chemical Pathology and Pharmacology 1978, 19:23-36.
91. Tegeder I., Grosch S., Schmidtko A., Haussler A., Schmidt H., Niederberger E., Scholich K., Geisslinger G. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Research 2003, 63:1846-1852.
92. Thornton S.R., Wang A.F., Smith F.L. Characterization of neonatal rat morphine tolerance and dependence. European Journal of Pharmacology 1997, 340:161-167.
93. Vathy I., Slamberova R., Rimanoczy A., Riley M.A., Bar N. Autoradiographic evidence that prenatal morphine exposure sex-dependently alters mu-opioid receptor densities in brain regions that are involved in the control of drug abuse and other motivated behaviors. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2003, 27:381-393.
94. Vernon B.M. Perceptual Neuroscience: The Cerebral Cortex 1998, Harvard University Press, Boston. 1st ed.
95. Virag L., Szabo E., Gergely P., Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicology Letters 2003, 140-141:113-124.
96. Walhovd K.B., Moe V., Slinning K., Siqveland T., Fjell A.M., Bjornebekk A., Smith L. Effects of prenatal opiate exposure on brain development-a call for attention. Nature Reviews Neuroscience 2009, 10:390.
97. Watkins L.R., Hutchinson M.R., Johnston I.N., Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends in Neurosciences 2005, 28:661-669.
98. Watkins L.R., Hutchinson M.R., Rice K.C., Maier S.F. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends in Pharmacological Sciences 2009, 30:581-591.
99. Watkins L.R., Maier S.F. Glia: a novel drug discovery target for clinical pain. Nature Reviews Drug Discovery 2003, 2:973-985.
100. Yin D., Tuthill D., Mufson R.A., Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. Journal of Experimental Medicine 2000, 191:1423-1428.
101. Zhang G.H., Sweitzer S.M. Neonatal morphine enhances nociception and decreases analgesia in young rats. Brain Research 2008, 1199:82-90.
102. Zhu H., Barr G.A. Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat. Pain 2003, 104:437-447.